An efficient design space exploration framework to optimize power-efficient heterogeneous many-core multi-threading embedded processor architectures

By the middle of this decade, uniprocessor architecture performance had hit a roadblock due to a combination of factors, such as excessive power dissipation due to high operating frequencies, growing memory access latencies, diminishing returns on deeper instruction pipelines, and a saturation of available instruction level parallelism in applications. An attractive and viable alternative embraced by all the processor vendors was multi-core architectures where throughput is improved by using micro-architectural features such as multiple processor cores, interconnects and low latency shared caches integrated on a single chip. The individual cores are often simpler than uniprocessor counterparts, use hardware multi-threading to exploit thread-level parallelism and latency hiding and typically achieve better performance-power figures. The overwhelming success of the multi-core microprocessors in both high performance and embedded computing platforms motivated chip architects to dramatically scale the multi-core processors to many-cores which will include hundreds of cores on-chip to further improve throughput. With such complex large scale architectures however, several key design issues need to be addressed. First, a wide range of micro- architectural parameters such as L1 caches, load/store queues, shared cache structures and interconnection topologies and non-linear interactions between them define a vast non-linear multi-variate micro-architectural design space of many-core processors; the traditional method of using extensive in-loop simulation to explore the design space is simply not practical. Second, to accurately evaluate the performance (measured in terms of cycles per instruction (CPI)) of a candidate design, the contention at the shared cache must be accounted in addition to cycle-by-cycle behavior of the large number of cores which superlinearly increases the number of simulation cycles per iteration of the design exploration. Third, single thread performance does not scale linearly with number of hardware threads per core and number of cores due to memory wall effect. This means that at every step of the design process designers must ensure that single thread performance is not unacceptably slowed down while increasing overall throughput. While all these factors affect design decisions in both high performance and embedded many-core processors, the design of embedded processors required for complex embedded applications such as networking, smart power grids, battlefield decision-making, consumer electronics and biomedical devices to name a few, is fundamentally different from its high performance counterpart because of the need to consider (i) low power and (ii) real-time operations. This implies the design objective for embedded many-core processors cannot be to simply maximize performance, but improve it in such a way that overall power dissipation is minimized and all real-time constraints are met. This necessitates additional power estimation models right at the design stage to accurately measure the cost and reliability of all the candidate designs during the exploration phase. In this dissertation, a statistical machine learning (SML) based design exploration framework is presented which employs an execution-driven cycle- accurate simulator to accurately measure power and performance of embedded many-core processors. The embedded many-core processor domain is Network Processors (NePs) used to processed network IP packets. Future generation NePs required to operate at terabits per second network speeds captures all the aspects of a complex embedded application consisting of shared data structures, large volume of compute-intensive and data-intensive real-time bound tasks and a high level of task (packet) level parallelism. Statistical machine learning (SML) is used to efficiently model performance and power of candidate designs in terms of wide ranges of micro-architectural parameters. The method inherently minimizes number of in-loop simulations in the exploration framework and also efficiently captures the non-linear interactions between the micro-architectural design parameters. To ensure scalability, the design space is partitioned into (i) core-level micro-architectural parameters to optimize single core architectures subject to the real-time constraints and (ii) shared memory level micro- architectural parameters to explore the shared interconnection network and shared cache memory architectures and achieves overall optimality. The cost function of our exploration algorithm is the total power dissipation which is minimized, subject to the constraints of real-time throughput (as determined from the terabit optical network router line-speed) required in IP packet processing embedded application

Hydrochemistry, water quality and land use signatures in an ephemeral tidal river : implications in water management in the southwestern coastal region of Bangladesh

Despite its complexity and importance in managing water resources in populous deltas, especially in tidal areas, literatures on tidal rivers and their land use linkage in connection to water quality and pollution are rare. Such information is of prior need for Integrated Water Resource Management in water scarce and climate change vulnerable regions, such as the southwestern coast of Bangladesh. Using water quality indices and multivariate analysis, we present here the land use signatures of a dying tidal river due to anthropogenic perturbation. Correlation matrix, hierarchical cluster analysis, factor analysis, and bio-geo-chemical fingerprints were used to quantify the hydro-chemical and anthropogenic processes and identify factors influencing the ionic concentrations. The results show remarkable spatial and temporal variations (p <0.05) in water quality parameters. The lowest solute concentrations are observed at the mid reach of the stream where the agricultural and urban wastewater mix. Agricultural sites show higher concentration of DO, Na+ and K+ reflecting the effects of tidal spill-over and shrimp wastewater effluents nearby. Higher level of Salinity, EC, Cl-, HCO3 (-), NO3 (-), PO4 (3-) and TSS characterize the urban sites indicating a signature of land use dominated by direct discharge of household organic waste into the waters. The spatial variation in overall water quality suggests a periodic enhancement of quality especially for irrigation and non-drinking purposes during monsoon and post-monsoon, indicating significant influence of amount of rainfall in the basin. We recommend that, given the recent trend of increasing precipitation and ground water table decrease, such dying tidal river basins may serve as excellent surface water reservoir to supplement quality water supply to the region.Peer reviewe

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

BACKGROUND: A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. METHODS: This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. FINDINGS: Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0-75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4-97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8-80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3-4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. INTERPRETATION: ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials. FUNDING: UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D'Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. Methods This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. Findings Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0–75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4–97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8–80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3–4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. Interpretation ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials

CASPER: Embedding Power Estimation and Hardware-Controlled Power Management in a Cycle-Accurate Micro-Architecture Simulation Platform for Many-Core Multi-Threading Heterogeneous Processors

Despite the promising performance improvement observed in emerging many-core architectures in high performance processors, high power consumption prohibitively affects their use and marketability in the low-energy sectors, such as embedded processors, network processors and application specific instruction processors (ASIPs). While most chip architects design power-efficient processors by finding an optimal power-performance balance in their design, some use sophisticated on-chip autonomous power management units, which dynamically reduce the voltage or frequencies of idle cores and hence extend battery life and reduce operating costs. For large scale designs of many-core processors, a holistic approach integrating both these techniques at different levels of abstraction can potentially achieve maximal power savings. In this paper we present CASPER, a robust instruction trace driven cycle-accurate many-core multi-threading micro-architecture simulation platform where we have incorporated power estimation models of a wide variety of tunable many-core micro-architectural design parameters, thus enabling processor architects to explore a sufficiently large design space and achieve power-efficient designs. Additionally CASPER is designed to accommodate cycle-accurate models of hardware controlled power management units, enabling architects to experiment with and evaluate different autonomous power-saving mechanisms to study the run-time power-performance trade-offs in embedded many-core processors. We have implemented two such techniques in CASPER–Chipwide Dynamic Voltage and Frequency Scaling, and Performance Aware Core-Specific Frequency Scaling, which show average power savings of 35.9% and 26.2% on a baseline 4-core SPARC based architecture respectively. This power saving data accounts for the power consumption of the power management units themselves. The CASPER simulation platform also provides users with complete support of SPARCV9 instruction set enabling them to run a full operating system software stack, and hence a wide variety of benchmarking applications